These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18453861)

  • 41. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diversity of MHC class I haplotypes in cynomolgus macaques.
    Saito Y; Naruse TK; Akari H; Matano T; Kimura A
    Immunogenetics; 2012 Feb; 64(2):131-41. PubMed ID: 21881951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic plasticity of the MHC class I A region in rhesus macaques: extensive haplotype diversity at the population level as revealed by microsatellites.
    Doxiadis GG; de Groot N; Otting N; Blokhuis JH; Bontrop RE
    Immunogenetics; 2011 Feb; 63(2):73-83. PubMed ID: 20949353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.
    Sugimoto C; Watanabe S; Naruse T; Kajiwara E; Shiino T; Umano N; Ueda K; Sato H; Ohgimoto S; Hirsch V; Villinger F; Ansari AA; Kimura A; Miyazawa M; Suzuki Y; Yamamoto N; Nagai Y; Mori K
    PLoS One; 2010 Jul; 5(7):e11678. PubMed ID: 20652030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diversity of MHC class I genes in Burmese-origin rhesus macaques.
    Naruse TK; Chen Z; Yanagida R; Yamashita T; Saito Y; Mori K; Akari H; Yasutomi Y; Miyazawa M; Matano T; Kimura A
    Immunogenetics; 2010 Sep; 62(9):601-11. PubMed ID: 20640416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.
    Tsukamoto T; Takeda A; Yamamoto T; Yamamoto H; Kawada M; Matano T
    J Virol; 2009 Sep; 83(18):9339-46. PubMed ID: 19587045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of MHC class I diversity on immune control of immunodeficiency virus replication.
    Goulder PJ; Watkins DI
    Nat Rev Immunol; 2008 Aug; 8(8):619-30. PubMed ID: 18617886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A; Walker BD
    AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract]   [Full Text] [Related]  

  • 49. Houdini's box: towards an understanding of AIDS virus escape from the cytotoxic T-lymphocyte response.
    O'Connor DH; Watkins DI
    Immunogenetics; 1999 Nov; 50(3-4):237-41. PubMed ID: 10602884
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.
    Yasutomi Y; Palker TJ; Gardner MB; Haynes BF; Letvin NL
    J Immunol; 1993 Nov; 151(9):5096-105. PubMed ID: 7691965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
    Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
    Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA
    Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
    Allen TM; Jing P; Calore B; Horton H; O'Connor DH; Hanke T; Piekarczyk M; Ruddersdorf R; Mothé BR; Emerson C; Wilson N; Lifson JD; Belyakov IM; Berzofsky JA; Wang C; Allison DB; Montefiori DC; Desrosiers RC; Wolinsky S; Kunstman KJ; Altman JD; Sette A; McMichael AJ; Watkins DI
    J Virol; 2002 Oct; 76(20):10507-11. PubMed ID: 12239328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241-249 epitope.
    Tsukamoto T; Dohki S; Ueno T; Kawada M; Takeda A; Yasunami M; Naruse T; Kimura A; Takiguchi M; Matano T
    AIDS; 2008 May; 22(8):993-4. PubMed ID: 18453861
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.